Zevra Therapeutics
ZVRA
#7261
Rank
HK$4.50 B
Marketcap
HK$76.13
Share price
1.94%
Change (1 day)
-10.27%
Change (1 year)

Earnings for Zevra Therapeutics (ZVRA)

Earnings in 2026 (TTM): HK$1.10 Billion

According to Zevra Therapeutics's latest financial reports the company's current earnings are HK$0.12 Billion. In 2025 the company made an earning of HK$0.74 Billion, an increase over its 2024 earnings that were of -HK$0.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zevra Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$1.10 B49.05%
2025 HK$0.74 B-214.33%
2024 -HK$0.65 Billion107.97%
2023 -HK$0.32 Billion-5.55%
2022 -HK$0.34 Billion418.02%
2021 -HK$63.8 Million44.87%
2020 -HK$44.04 Million-68.85%
2019 -HK$0.15 Billion-63.58%
2018 -HK$0.39 Billion37.16%
2017 -HK$0.29 Billion283.79%
2016 -HK$73.74 Million-81.21%
2015 -HK$0.4 Billion130.03%
2014 -HK$0.18 Billion